novo nordisk glp 1 drugs Ozempic's patent problem: how lost control of a blockbuster drug. ๐ Demand for GLP-1 weight-loss has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite Novo Nordisk's oral GLP-1 drug
Pay in 4 interest-free payments of $6.60 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 22 - Aug 27


























